ArrowMark Partners is an SEC-registered investment adviser. The company's investment objective is clear: deliver consistent, asymmetric, non-correlated, risk-adjusted returns by applying fundamental research across the capital structure.
100 Fillmore Street
Colorado, United States
|2020-02-13||StoneCastle Cash Management - Bank Investment Platform||Acquired Unit|
|2020-01-27||Lyra Therapeutics||Series C||$30M||Clifton Capital, InterSouth Partners, North Bridge Venture Partners, Perceptive Advisors, Polaris Partners, RA Capital Management, and Soleus Capital Management|
|2019-12-26||Sonendo||Series F||$85M||Broadfin Capital, CVF Capital Partners, EW Healthcare Partners, General Atlantic, JMR Capital, Meritech Capital Partners, Neomed Management, OrbiMed Advisors, Perceptive Advisors, Redmile Group, SEB Private Equity, and Security Pacific Finance|
|2019-12-17||ArcherDx||Series C||$55M||Boulder Ventures, Driehaus Capital Management, Longwood Fund, PBM Capital Group, Perceptive Advisors, Redmile Group, Sands Capital Ventures, Soleus Capital Management, and Undisclosed Investors|
|2019-12-09||StoneCastle Asset Management||Acquired|